about
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimationPrescribing of neuraminidase inhibitors for influenza in UK primary care since the 2009 pandemicAssessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.Excess mortality monitoring in England and Wales during the influenza A(H1N1) 2009 pandemic.Seroepidemiologic study of pandemic (H1N1) 2009 during outbreak in boarding school, EnglandEffectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010.Estimating the prevalence of chronic conditions in children who die in England, Scotland and Wales: a data linkage cohort study.Contribution of respiratory tract infections to child deaths: a data linkage study.Recording of Influenza-Like Illness in UK Primary Care 1995-2013: Cohort Study.Stillbirth and neonatal death rates across time: the influence of pregnancy terminations and birth defects in a Western Australian population-based cohort study.Chronic conditions in children and young people: learning from administrative dataData Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC).Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012.Epidemiology of laboratory-confirmed respiratory syncytial virus infection in young children in England, 2010-2014: the importance of birth month.Who comes back with what: a retrospective database study on reasons for emergency readmission to hospital in children and young people in England.Factors associated with influenza vaccine uptake during a universal vaccination programme of preschool children in England and Wales: a cohort study.Contribution of recurrent admissions in children and young people to emergency hospital admissions: retrospective cohort analysis of hospital episode statistics.Investing in national primary care data is way forward in time of care.data.Accurate data on all injury deaths is vital for monitoring suicide prevention.Rubella seroprevalence in pregnant women in North Thames: estimates based on newborn screening samples.Where do the differences in childhood mortality rates between England and Wales and Sweden originate?How can we make international comparisons of infant mortality in high income countries based on aggregate data more relevant to policy?Effectiveness of live attenuated influenza vaccine in preventing amoxicillin prescribing in preschool children: a self-controlled case series study.Risk factors for admission to hospital with laboratory-confirmed influenza in young children: birth cohort study.Characteristics and mortality risk of children with life-threatening influenza infection admitted to paediatric intensive care in England 2003-2015.Child mortality in England compared with Sweden: a birth cohort study.Emergency admissions and long-term conditions during transition from paediatric to adult care: a cross-sectional study using Hospital Episode Statistics data.Impact of the introduction of a universal childhood influenza vaccination programme on influenza-related admissions to paediatric intensive care units in England.Corrigendum to characteristics and mortality risk of children with life-threatening influenza infection admitted to paediatric intensive care in England 2003–2015 [Respir. Med. 137 (2018) 23–29]Analysis of rubella antibody distribution from newborn dried blood spots using finite mixture modelsAgreement of rubella IgG antibody measured in serum and dried blood spots using two commercial enzyme-linked immunosorbent assaysChapter 5 Rubella Epidemiology: Surveillance to Monitor and Evaluate Congenital Rubella Prevention StrategiesUniversal HIV testing in London tuberculosis clinics: a cluster randomised controlled trialAvoidable mortality from respiratory tract infection and sudden unexplained death in children with chronic conditions: a data linkage studyThe contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East EnglandNeonatal screening for inborn errors of metabolismPreventing child deaths: what do administrative data tell us?
P50
Q28742436-686F111E-98D6-4239-A23C-74226F5D07AFQ30379123-D71E5B69-E64E-446B-8E0C-166650177833Q30398249-E9F8934E-148B-4796-BC36-5DDE60405AE1Q30398764-01706F7D-0B1A-4196-8D19-8A67008FED81Q30401166-EF389D93-E08C-43D9-90C7-90114606BFDFQ30406692-F24275BE-322C-48E3-9276-2B9C38D344EDQ30410814-B81F2170-EFA0-408C-83EE-E89F7406525EQ30414118-996BB151-CC23-4DB9-A826-371D01FF006BQ30840205-AD215D13-110D-4AE2-BB5C-D432770412EEQ34587026-CA1474D8-88D3-4574-AEBB-DDE6F2792486Q35782020-8D633BEB-6477-4770-8196-7FF97D920044Q36020132-5B7AB42B-0BAB-4019-85E8-78A5B0D661A5Q36035439-89029783-8D23-42C0-A36B-72C1671A2F29Q36321893-44636CBB-35F5-43F7-9C88-43A13365EF2DQ37638405-A5672E26-4988-4CD0-8292-F885881F061AQ38903197-7AAB4E09-4F46-4937-AF4F-440429A78F46Q39822702-2E78F65A-3E74-4EBF-9541-CCD91E03EAD1Q40755414-CA8FDEC8-6C21-484D-AF10-FA932F3717FDQ40925837-45C5FA4F-D705-4CBD-90BF-10426643D67DQ44026183-E77ABA12-60F0-4E89-A861-2B377EB19803Q46173188-7CDD1E8B-ECFF-4AF8-B4CC-6CC657376E91Q46307994-CEECDA99-77B2-4E90-9234-B25CA9860531Q46818278-21A1D0DD-C160-40BA-A8C8-B3ADD41D5678Q47116168-26C69FBB-D47A-4D61-981C-886FD274A0FEQ47580274-FE16992C-D83B-44E5-B7E9-E62515F4EE87Q47910350-A9AE8DEC-E556-4622-A2F0-102A61A90B77Q52802361-75CBE92C-D5B6-4AE7-A003-251A7333F2C7Q55267078-05C57566-93B8-418A-A3DA-82134872AA51Q55399902-4FC9E1E2-BD32-4793-8112-0AA8A2CB2385Q55401699-F5815034-20F5-417C-BEB2-29D3EFD749FFQ56835612-9BA2071F-A532-4A28-B37B-097D201BC7EBQ57076317-D5425024-6145-4F50-B7A2-E02C60469F79Q57076330-FE316E39-FDFE-451A-8E1A-EBDDBDA07AF7Q57076337-DAD11ED6-4A6E-4AB2-BC7E-FB999ED50809Q57277989-5B34295F-C400-46CC-BFDB-FC74545438E5Q59677561-0D854901-D007-4CD5-A099-0DE4CB195722Q61451414-377368A6-B353-48BE-9E1F-CFC888781007Q80469346-D11BDB7B-ED27-4D22-B7E9-8998C2DBBABEQ81889105-87D06D90-46E3-4868-8455-6EF9ADFA76BFQ91995071-41A467A5-C6E4-436D-BFF0-77F25F557B55
P50
description
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Pia Hardelid
@ast
Pia Hardelid
@en
Pia Hardelid
@en-gb
Pia Hardelid
@es
Pia Hardelid
@nl
Pia Hardelid
@sl
type
label
Pia Hardelid
@ast
Pia Hardelid
@en
Pia Hardelid
@en-gb
Pia Hardelid
@es
Pia Hardelid
@nl
Pia Hardelid
@sl
prefLabel
Pia Hardelid
@ast
Pia Hardelid
@en
Pia Hardelid
@en-gb
Pia Hardelid
@es
Pia Hardelid
@nl
Pia Hardelid
@sl
P106
P31
P496
0000-0002-0154-1306